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    µl                                                      Microliter 
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    bp                                                     Base pare 
  cDNA                                               Complimentary DNA 
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ABSTRACT 
 
DNA Methylation acts as an essential regulatory mechanism of transcription affecting 
chromatin structure, which is established and properly maintained by the co-ordinate action 
of three DNA methyltransferases: DNMT1, DNMT 3A and 3B and histone 
modifications.DNMT1 is constitutively expressed and is required for the maintenance of 
global methylation after DNA replication. In contrast, the DNMT3 family genes appear to be 
developmentally regulated and behave like de novo DNA methyltransferases in vitro . Recent 
studies show that epigenetic change plays a major role in silencing a variety of methylated 
tissue-specific and imprints genes in many cancer types. The DNMT3A and DNMT3B show 
high homology in the carboxy terminal catalytic domain and contain a conserved cysteine 
rich region which allocate homology with the X-linked ATRX gene of the SNF2/SWI family. 
In this study, we have cloned human DNMT3Aand DNMT3B. This cloning of the human 
DNMT3 genes will facilitate further biochemical and genetic studies of their functions in 
establishment of DNA methylation patterns, regulation of gene expression and tumorigenesis. 
 
 
 
 
 
 
 
 
 
Key words:- DNA Methylation, DNMTs, ATRX gene, SNF2/SWI family 
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2. INTRODUCTION 
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The term “epigenetic” was coined by Conrad Waddigton in 1940s according to him 
“Epigenetics is the study of heritable changes in phenotype or gene expression caused by 
mechanisms other than changes in the underlying DNA sequence”. These alterations may 
remain through out the cell divisions for the remainder of the cell's life and may also last for 
multiple generations .  Epigenetic be noticeable in the literature as far as the mid 19th century, 
although the conceptual origins data back to Aristatol (384-322 B.C). He conceived in 
epigenesist in the development of individual organic form from the unformed. This 
argumental view was the main argument against our having developed from miniscule fully 
formed bodies. Epigenetics is appear to form and take shape as a new scientific discipline, 
which will have deep impact on Medicine and Approximately all fields of biology.  
 
 
Figure1. Epigenetic modification (Madame Curie Bioscience and database) 
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Epigenetics covers many different levels of biological control from variegated expression in 
Drosophila to chromatin structure and modification down to DNA methylation and relates to 
different biological systems. Epigenetics affect the transcription in the cell, thereby managing 
gene expression and abnormal epigenetic changes can have serious effects for the organism. 
Most epigenetic modification only occur within the course of one individual organism’s 
lifetime, but if a alteration in the DNA has been caused in gamete that result in fertilization, 
then some epigenetic modification are inherited from one generation to the next - 
“Lamarckism”. We can very roughly branch epigenetics into three substantially overlapping 
categories: DNA methylation, genomic imprinting, and histone modification. Among these 
mechanisms, DNA methylation  is the main focus of  my thesis. The epigenome is comprised 
of chromatin and its associated proteins. Pattern of covalent modifications of DNA by 
methylation setup and maintains gene expression patterns. 
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3. REVIEW OF LITERATURE 
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Review of literature 
In the post genomic era of cancer biology it is becoming increasingly evident that epigenetic 
controls of gene expression play an important role in determining the phenotype of cancer 
cell. Maintenance of balance between cell proliferation and cell death is the main key of 
appropriate development. Cancer cells have higher rate of proliferation than death.( Patra, S. 
K. Biochimica et Biophysica Acta 1785 (2008) 182–206). Histone modifications and 
DNAmethylationand demethylation events are central to the epigeneticregulations of 
development [Reik,W et al 2001, Surani et al 2002, Judso et al 2002, Hata et al 
2002,Bourc’his,D. Et al 2001, Mc Lay et al 2003, Haaf, t. Et al 2006]. The mechanisms 
controlling these events and their dynamic changes have important implications in 
developmental cell biology as well as carcinogenesis and tumour progression. 
 
DNA methylation 
 
Methylation of DNA was discovered by R.D. Hotchkiss while separating and 
quantifying DNA bases from nuclear preparations.(Hotchkiss .R.D et al, 1948)DNA 
methylation acts an powered role in regulation of gene expression (Kass et al., 1997), 
genomic-imprinting (Bartolomei and Tilghman, 1997), and Xchromosome inactivation 
(Jaenisch et al., 1998), and has been shown to be main point for mammalian development (Li 
et al., 1992).Mammalian cells have the capacity to epigenetically modifytheir genomes via 
DNA methylation. Methylation at the C-5 position of cytosine within CG dinucleotidesis an 
epigenetic modification critical for normal development,differentiation, gene regulation and 
control of chromatinstructure in mammalian cells . 
5 methylcytosines account for about 1% of total DNA bases in the human genome and 
affects 70-80% of the CpG sites in a human somatic cell (M Ehrlich at al 1986). 
Approximately 70% of the CpG residues in themammalian genome are methylated, however 
the allocation of CpG is not random and the majority of the genome is CpG-poor(Cooper et al 
1989). Certain regions of the genome which are often, but not always, clustered at the 54-
ends of genes possess the probable CpG frequency and have been termed CpG islands . CpG 
methylation has been collaborative with reduced transcription (Bird, A. P et al 1992, Kass, S. 
U et al  1997, Razin, A. Et al1998), decreased DNase I sensitivity (Keshet, I et al 1986), and 
decreased site-specific recombination (Hsieh, C-L at al 1992).DNA methylation is a covalent 
modification of nucleotides and the most frequently occur in cytosine bases of DNA 
sequence. The cytosine is methylated in the C-5 position byC-C covalent bonding with the 
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help of  universal methyl donor Sadenosyl- L-methionine (SAM) in association of  a family 
of DNA (cytosine-5) methyltransferases (DNMTs)  and here SAM changes to S-
adenosylhomocystein (Razin,A et al 1984, Adams, R.L.P et al1985,Jost et al1993,Jones et al 
2007, Christman et al 2002, S.K Patra et al 2008). 
 
 
 
Figure.2: Methylation of cytosine catalyzed by DNMTs. ( C.P. Walsh and G.L. Xu. 
Curr Top Microbiol Immunol., 2006, 301, 283-315) 
 
DNA Methyltransferases (DNMTs):- 
 
The mammalian DNMTs family encompasses DNMT1, DNMT2, DNMT 3. DNMT 3 
family consists of two related genes, termed DNMT 3A and DNMT 3B. 
 
 
 
Figure.3: Members of mammalian DNMTs family(Takeshima et al. (2006) J. Biochem. 139, 
505-515.) 
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This family is divided into maintenance and de novo Methyltransferases. DNMT1 is 
specialized to carry out most of the maintenance methylation following DNA replication, 
whereas DNMT3A and DNMT3B are capable for de novo methylation during embryogenesis 
and germ cell development (Cooper et al 1989) Maintenance DNMT1 binds methyl groups to 
the hemimethylated DNA in the time of replication, where as de novo DNMT3A and 
DNMT3B add methyl groups to CpG dinucleotides of unmethylated DNA .DNMT1, 
DNMT3A and DNMT3B are required for formation of the established pattern of methylation 
in promoters and first exons of human genomic DNA (Das PM et al  2004). 
Hypermethylation and repression of selective genes by ectopic expression of DNMTs be 
present unclear. Present molecular genetic and enzymatic/proteomic data suggest that 
DNMT1 and DNMT3a trigger class I histone deacetylases (HDACs) to precipitate inactive 
chromatin. (Patra S.K. et al 2001) Among these my topic based on DNMT 3A and DNMT 
3B. 
  
 
 
 
 
Fig.4:-Pattern of  DNA Methylation (Peter A. Jones & Gangning Liang 
Nature Reviews Genetics 10, 805-811 ( 2009) 
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DNMT3A and DNMT3B is active without interaction with their N-regulatory regions. 
The N-terminal domain possesses nuclear localization signal sequence (NLS) responsible for 
localization of DNMTs in the nucleus. The N-terminal end of of DNMTs also contains 
proliferating cell nuclear antigen binding domain (PDB), a cysteine rich zinc finger DNA 
binding motif (ATRX), and polybromo homology domain (PHD) targeting DNMTs to the 
replication foci. However, PWWP tetra peptide is only present in N-terminal domains of 
DNMT3A and DNMT3B and interact with histones (Hermann A et al 2004). The C-terminal 
domain contains six motifs I, IV, VI, VIII, IX and X. Motifs I and X form S-
adenosylomethionine binding site, motif IV associate with cytosine at the active site, motif 
VI possesses glutamyl residue giving protons, and motif IX maintains the structure of the 
target recognition domain (TRD) usually spotted between motifs VIII and IX, that form base-
specific contacts in the chief groove of DNA (Bestor TH et al 2000, Robertson KD et al 
1999, Weisenberger DJ 2004 , . Xie S et al 1999 ) 
DNMT 3A 
 
DNA (cytosine-5)-methyltransferase 3A is an enzyme that in humans is encoded by 
the DNMT3A gene. This gene encodes a DNA methyltransferase that do function in de novo 
methylation.The protein localizes to the cytoplasm and nucleus and its expression is 
developmentally balanced. Another splicing results in multiple transcript variants encoding 
different isoforms. It was identified by EST database searces in 1998 using the conserved 
methyltransferase motif as bait. It is found in human chromosome 2p23. It has 96% 
aminoacid identity with murine dnmt3a gene. DNMT 3A is ubiquitously expressed in adults 
tissues , most tumor types , cell embryos and embryonic stem cells. 
Structure of DNMT 3A:- 
It contain an Amino terminal domain and a carboxyterminal domain. 
(a) Amino terminal domain 
 It contains a PWWP domain ant a ATRX motif in the N-terminal 
PWWP domain: A domain contain a highly conserved “proline- tryptophan-tryptophan-
proline” motif involved in heterochromatin association. 
ATRX motif: An ATRX related cystein rich region containing a C2-C2 zinc finger and an 
atypical PHD (Plant homo domain) implicated in protein protein interaction. 
                                     This characterise that DNMT 3A and DNMT 3B may be associated 
with structural change in chromatin via protein-protein interactions at the amino terminal 
region. 
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(b) Carboxyterminal domain 
 
The catalytic motifs are highly conserved in all cytosine DNMTs. 
 
 
 
 
  
 
 
 
 
 
Figure.5: Structure of  DNMT 3A (Atlas of Genetics and Cytogenetics in Oncology and 
Haematology) 
 
 
Function: 
Essential for genome wide de novo methylation and it is essential for the establishment of 
DNA methylation patterns during development process. Methylation of DNA is coordinated with 
methylation of histones. It changes DNA in a non-processive manner and also methylates non-
CpG sites. It may mostly methylate DNA linker between 2 nucleosomal cores and is repressed by 
histone H1. Plays a crucial role in paternal and maternal imprinting. This is essential for 
methylation of most imprinted loci in germ cells. It acts as a transcriptional co-repressor for 
ZNF238.Can actively repress transcription through the recruitment of HDAC activity.DNA 
methyltransferase (DNMT) add methyl groups to DNA to effect gene expression. Basically there 
are three main types of DNMTs. DNMT1 is predominately capable for hemi-methylated CpG 
island methylation, DNMT2 transfers methyl groups to RNA in state of DNA. Hence, has been 
renamed to t-RNA aspartic acid methyltransferase 1 (TRDMT1) and DNMT3 is responsible for 
unmethylated CpG island methylation.  
  
DNMT 3B 
 
DNA (cytosine-5)-methyltransferase 3 beta, also known as DNMT3B, is a protein 
associated with immunodeficiency, centromericdivergence and facial anomalies syndrome. CpGs 
methylation is a type of epigenetic modification that is important for embryonic development, 
N- terminal regulatory domain 
C- terminal catalytic domain 
 V V X X 
PWWP ATRX 
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imprinting, and X-chromosome inactivation. DNMT3B gene encodes a DNA methyltransferase 
which is thought to function in de novo methylation, rather than maintenance methylation. This 
protein localizes primarily to the nucleus and its expression is developmentally regulated. It was 
identified by EST database searches in 1988. This gene is mapped to human chromosome  
20 q11.2 . It has 85% amino acid identify with DNMT 3B of mouse. DNMT is expressed high 
levels in testes and play a crucial role in spermatogenesis. 
Structure of DNMT 3B:- 
It contain an Amino terminal domain and a carboxyterminal domain. 
(a) Amino terminal domain 
It contains a PWWP domain and a ATRX motif in the N-terminal. 
(b)   Carboxyterminal domain 
The catalytic motif are highly conserved in all cytosine DNMTs. 
 
 
 
 
 
 
 
 
 
 
Figure.6 : Structure of  DNMT 3B (Atlas of Genetics and Cytogenetics in Oncology and 
Haematology) 
Function: 
DNMT3B both maintain DNA methylation and gene silencing in human cancer cells. 
DNMT3B may not only silence genes by direct DNA methylation or recruitment of proteins that for 
chromatin modification, but also play an essential role in transformation .Required for genome wide 
de novo methylation and is essential for the establishment of DNA methylation patterns during 
development. DNA methylation is associated with methylation of histones. This preferentially 
methylates nucleosomal DNA within the nucleosomal core region. This May function as 
transcriptional co-repressor by associating with CBX4 and independently of DNA methylation 
involved in gene silencing. In association with DNMT1 & and via the recruitment of 
CTCFL/BORIS associate in activation of BAG1 gene expression by modulating demethylation of 
promoter histone H3 at H3K4 and H3K9. Isoforms 4 and 5 are hopefully not functional due to the 
N- terminal regulatory domain 
C- terminal catalytic domain 
 II V X X 
ATRX PWWP 
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deletion of two conserved methyltransferase motifs. DNA-methyltransferase-3B carried out an 
important role in the generation of aberrant methylation in carcinogenesis. Polymorphisms and 
haplotypes of the DNMT3B gene may influence DNMT3B activity on DNA methylation, thereby 
altering the affectivity to lung cancer. The DNMT3B gene has two transcriptional start sites, which 
exist in different exons (exon 1Aand1B) and the expression is regulated by variety of promoters. 
One promoter is nested within a CpG-rich area, whereas the additional promoter is found in CpG 
poor. (Lee, et al., volume 26) 
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OBJECTIVE  
DNA methylation and DNA demethylation are two different, exactly opposite, 
conceptually defined chemical reactions similar to other epigenetic modifications such as 
acetylation and deacetylation, phosphorylation and dephosphorylation, which are frequently 
encountered while studying the dynamics of the epigenome. 
Keeping this hypothesis in mind and based on the literature survey, the present work 
has been undertaken on two proteins DNMT 3A and 3B for their further characterisation. 
And the objectives of the project include:- 
Cloning of DNMT3A and DNMT3B. 
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Material and Methods 
RNA extraction:- 
Extraction from Blood By RNA Purification Kit:- 
The collected cancer blood was centrifuged at 3000 rpm for 15mins at 4° C. The 
supernatant containing the serum was separated from the pellet which contains the blood 
cells. The pellet was resuspended in 600µl of Lysis Buffer (supplemented with 20µl of 14.3 
M β-mercaptoethanol for every 1ml of Lysis Buffer) and vortexes to mix thoroughly. 450µl 
of ethanol (96-100%) was mixed with the solution. About 700µl of the lysate was transferred 
to a GeneJETTM RNA Purification Column inserted in a collection tube and centrifuged at 
12000 rpm for 1 min at 4° C. The flow-through was discarded and the column was placed 
into a new 2 ml RNase-free micro centrifuge tube. 700µl of Wash Buffer 1(supplemented 
with 250µl of ethanol for every 1ml Wash buffer I) was added to the column and centrifuged 
for 1 min at 12000 rpm. The flow-through was discarded and 600µl of Wash Buffer II 
(supplemented with 850µl of ethanol for every 0.5µl Wash buffer II) was added to the 
column. It was centrifuged at 12000 rpm for 1 min at 4° C. The flow-through was again 
discarded. Centrifugation was again done at 12000 rpm for 1 min at 4 ° C by adding 250µl of 
Wash buffer II. The flow-through was discarded and the column was transferred to a sterile 
1.5ml RNase-free microcentrifuge tube. 100µl of nuclease-free water was added to the 
column and centrifuged for 1 min at 12000 rpm to elute RNA. The RNA was stored at - 20° 
C for further use or immediately processed for cDNA synthesis. 
RNA quantification by Nanodrop:- 
                By measuring the absorbance at 260 nm the concentration of the extracted total 
RNA from cancer tissue was quantified (Table 1) in a nanodrop and calculated by using the 
formula as given below: 
Total RNA (µg /ml) = OD260 × 40 × Dilution factor. 
First strand cDNA synthesis:- 
Total RNA (4µg) from cancer tissue were used for first strand cDNA synthesis by 
reverse transcription using RevertAidTM First Strand cDNA Synthesis Kit (Fermentas) in a 
thermocycler . The RNA were incubated with 1 µl of oligo (dT)
  
primers (100µM, 0.2 µg/µl) 
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and 12 µl of nuclease-free water at 65 °C for 5 min. The reaction was cooled on ice to allow 
the primers to anneal to the RNA, then spin down and placed on ice again after which the 
following components were added to the reaction in order; 4 µl of 5X Reaction Buffer, 1 µl 
of RibolockTM RNase inhibitor (20 U/µl), 2 µl of 10 mM dNTPs and 1.0 µL of RevertAidTM 
M-MuLV-Reverse Transcriptase (200 U/µl). The reagents were gently mixed and incubated 
for 1 hr at 42°C. Heating at 70°C for 5 min terminated the reaction and the synthesized 
cDNA was stored at –20 0 C for further use. 
Gene-specific PCR for amplification of the desired gene:- 
Selection of Primers:- 
A set of specific forward and reverse primers for the amplification of the desired gene 
DNMT 3A and DNMT 3B was selected from published papers ( Patra, S. K. et al., 2003; Zou 
et al., 2002). The cDNA of both the blood and cancer tissue synthesized were used as the 
template for the specific primers. The constitutively expressed housekeeping gene β-actin was 
used as a positive control to ensure high quality of cDNA. The primer sequences used for the 
PCR reaction are shown. 
PCR amplification of DNMT 3A, 3B gene 
 For amplification of specific gene sequence such as TLR 22 gene present in cDNA is 
we required that gene specific forward and reverse primer. 
• 0.2 µMdNTP- 0.5µl  
• 1.5 mM MgCl2- 1.5µl  
• 1x PCR Buffer- 2.5µl  
• TaqPolymearse (5U/µl)- 0.5µl  
• Primers (0.2µM)- 0.5µl & 0.5µl  
• cDNA- 2µl  
•  MQ Water- 17µl  
 
 
PCR Mixture:- (Total 25µl)  
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Methods:- 
Autoclaved PCR tubes were labelled according to the samples. A master mix of 1 
reaction was prepared  in a sterilize eppendrof  tube by adding 40.8µl of autoclaved Millipore 
water, 5µl of 10xTaq assay buffer,1 µl forward primer,1 µl reverse primer, 1 µl dNTPs and 
0.2 µl of TaqDNA  polymerase, then mixed properly by short spin and kept it in ice.1 µl 
cDNA was taken from each sample and was put into the labelled PCR tube accordingly, Keep 
one negative control ( without cDNA ).The tubes were tapped gently and spined for few 
seconds. After this the tubes were placed in thermal cycler with program set as follows for 
DNMT 3A and DNMT 3B:- 
                   94cc for 1 min (Initial denaturation) 
                   940c for 20 sec ( Denaturation) 
               650c for 20 sec (Annealing) 42 cycle 
               720c for 30 sec (Extension) 
                720c for 5 min (Final extension)   
 
 
                   94cc for 1 min (Initial denaturation) 
                   940c for 20 sec ( Denaturation) 
             580c for 20 sec (Annealing) 42 cycle 
             720c for 30 sec (Extension) 
            720c for 5 min (Final extension)   
 
40c hold on forever 
• The reaction product was then stored at -200c until further analysis. 
• Then analyse of the PCR amplified product was done in 2% gel.(Fig:- 9) 
Gel elution 
The DNA fragment of Interest was excise from the agarose gel with a clean, sharp  
razor blade. Cut away excess gel to minimize the amount of agarose. Then the sliced gel was 
kept in clean eppendrof tube. 300mL of Gel Solubilization Solution was added to the gel 
silica. Then the gel mixture was incubated at 50-60 °C for 10 minutes, or until the gel slice is 
completely dissolved. Vortex briefly every 2-3 minutes during incubation to help dissolve the 
gel. GenElute Binding Column G was placed into one of the provided 2 ml collection tubes. 
DNMT 3A 
DNMT 3B 
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Then 500mL of the column Preparation Solution was added to each binding column. 
Centrifuged for 1 minute and discarded the flow through liquid. Here yellow colour solution 
was found. 2 gel volumes of 100% isopropanol were added to the solution. Solubilised gel 
solution mixture was added into the binding column that was assembled in a 2 ml collection 
tube. Then the column was Centrifuge for 1 minute after loading the column each time. Flow 
through liquid was discarded. 700mL of Wash Solution was added to the binding column and 
centrifuged it for 1 minute.  The binding column was then removed from the collection tube 
and discards the flow-through liquid. The binding column was placed back into the collection 
tube and centrifuge again for 1 minute without any additional wash solution to remove excess 
ethanol. The binding column was transferred to a fresh collection tube. 50mL of pre heated 
elution Solution at 65 °C was added to the centre of the membrane and incubated for 1 
minute. Then Centrifuge for 1 minute. Supernatant containing DNA was carefully transferred 
to a new reaction tube. (Fig:-10) 
  
 
Preparation of ligation mixture 
Requirements:-  
• 2x rapid ligation buffer (Promega) 
• PCR product( Insert) 
• T4 DNA Ligase (Promega) 
• Vector-Here I use pBSK(-)(Fig:- 11) 
Methods:- 
Before use ligation buffer was vertexed properly and then short spinned. 
5µl of ligation mixture was prepared  in a sterilize eppendrof  tube by adding  2.5 µl of 
ligation buffer,1.5µl of PCR product(Insert),0.5 µl of  T4  DNA ligase and 0.5 µl of pBSK(-) 
vector. The reaction mixture was mixed properly by pipetting and incubated over night at 40c 
temperature.  
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Transformation:- 
Competent cell preparation:- 
 For the formation of competent cell we can’t take DH5α stain of E.coli directly which 
is present in glycerol stock solution because here the cell is present in stationary phage. So 
for this:-  
First  200 µl  of  DH5α  stain of  E.coli  was taken in a eppendroff  tube containing  2ml  LB. 
The culture was then incubated over night at 370c in water bath shaker to bring the bacteria to 
their log phase. From this culture 300 µl  of DH5α  stain was taken in an eppendroff  tube 
containing  100 ml of LB media. Then the tubes were incubated at 370 c temp. at water bath 
shaker .When  growth was observed  after 2 hr then 12ml of culture was taken in 15ml of 
tarson tube and immediately place it into ice box. Then the tubes were centrifuged at 5000 
RPM for 5 min at 40c temperature, supernatant was discarded. The pellets were dissolved into 
500µl of 0.1 µl Cacl2.This solution were then transferred into new eppendroff tubes and 
incubated in ice. After that the tubes were centrifuged at 5000RPM for 5 min at 40c and 
supernatant discarded. The pellets were dissolved into 100 µl of 0.1M Cacl2 and incubated 
for 15 min into ice. 
 
Incertion of vector to competent cell:- 
For the insertion of vector to competent cell exactly 100 µl of competent cell and 5 µl 
of ligation mixture were taken in a sterilised ependroff tubes. Then the tubes were 
immediately incubated in ice for 1hr.A brief heat shock was given at 420c exactly for 90 sec. 
and immediately chilling in ice for 15 minutes. Then the contents were transferred into tarson 
tube containing 1.5ml-2ml LB media. After that the contents were incubated over night at 
370c at water bath shaker. 
Blue white colony selection 
The blue-white screen is a molecular technique that allows for the determination of 
successful ligations in vector-based gene cloning. Insert is ligated into a vector. The vector 
with insert is then transformed into competent cell(Bacteria). The bacterial cells are then 
grown in the presence of X-gal. If the ligation process was successful the bacterial colony 
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will be white; if not, the colony will be blue in colour. This process allows for the quick and 
easy detection of successful ligation. 
                         The molecular mechanism for blue-white screening is based on a genetic 
engineering of the lac operon. The vector pBlueScript encodes the α subunit of LacZ protein 
with an internal multiple cloning site (MCS), while the chromosome of the host strain 
encodes the remaining Ω subunit to form a functional β-galactosidase enzyme. The Multiple 
cloning site can be cleaved by different restriction enzymes so that the foreign DNA can be 
inserted within the lacZα gene, because of that disrupting the production of functional β-
galactosidase. The chemical required for this screen process is X-gal, a colourless modified 
galactose sugar that is metabolized by β-galactosidase to form 5-bromo-4-chloro-indoxyl 
which is spontaneously oxidized to the bright blue in dissolvable  pigment 5, 5’-dibromo-4,4'-
dichloro-indigo, and because of that functions as a control indicator. Isopropyl β-D-1-
thiogalactopyranoside (IPTG), which works as the activator of the Lac operon. This IPTG 
can be used to enhance the phenotype. The hydrolysis of colourless X-gal by the β-
galactosidase causes the characteristic blue colour in the colonies; it shows that the colonies 
carry vector without insert DNA. White coloured colonies indicate insertion of foreign DNA 
and loss of the cells ability to hydrolyse the marker. 
Colony pick up:-  
For this process first LB Agar plate was prepared and kept it for solidification in side 
tha laminar air flow. After that 50µl of amphicilin was added when temperature falls to 
55-600c then spread this amphicilin with the help of spreader till dry. On that dried LB 
agar Amphicilin plate 120µl of master mix were added made up of   
                     IPTG-100µl  
                     X-gal-20 µl 
Then the master mix was spread with the help of spreader and roter. 
 After ½ -1hr 10µl of culture were put into the plate and spread well. Before the addition 
of culture 1st the culture was centrifuged at 5000 RPM for 5 min then thu supernatant were 
discarded and retained 200µl of supernatant. After that pellet was mixed with the 
supernatant and spread on the plate. After that the plate was put in side the incubator at 
370c for overnight. Here we found blue-white colonies.(Fig:- 12) 
 White colonies shoes that these are positive clones mean these bacteria have cloned 
plasmid. After that the white colonies were picked up with the help of tip and put in the 2ml 
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eppendroff tube containing 1.5ml lb agar media. Then the tubes were put in overnight 
incubation at 370c temperature at water bath shaker. After maximum growth observed we can 
proceed for plasmid isolation. 
Plasmid isolation from recombinant clones:- 
Requirements:- 
Alkaline lysis solution I 
Alkaline lysis solution II 
Alkaline lysis solution III 
Antibiotic for plasmid selection 
Ethanol 
Phenol: Chloroform 
LB Broth 
Methods:- 
White colonies which are expected to be recombinant were picked up with the help of 
tip and were grown in 1 ml LB media for overnight at 370c  in water bath shaker. 1.5 ml 
culture was then transferred into a microcentifuge tube and centrifuge at maximum speed for 
30 sec at 40C. After centrifugation the supernatant was removed by aspiration, then the pellet 
was dried as much as possible. The dried bacterial pellet was resuspended by 100µl of ice-
cold alkaline solution I by vigorous vortexing. Then 200 µl of freshly prepared alkaline 
solution II was added to the tube and mixed by inverting the tube rapidly 5 times. Tube was 
stored on ice. 150 µl of ice-cold alkaline solution III was added. Then the tube was closed 
and disperse the alkaline lysis solution III through the viscous bacterial lysat by inverting the 
tubes several times then stored it on ice for 3-5 min. Bacterial lysat was centrifuged at 
maximum for 5 min at 40C and then transferred the supernatant to a fresh tube. 2 volume of 
ethanol was added to the supernatant and mix it by vortexing and then allow the mixture to 
incubate for 2 min at room temperature. Then precipitated nucleic acid was collected by 
centrifugation at maximum speed for 5 min at 40C. The supernatant was removed by gentle 
aspiration and stand the tube in inverted position to allow all the fluid to drain out. 1ml 70% 
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ethanol was added to the pellet and inverted the tube several time.DNA was recovered by by 
centrifugation at maximum speed for 2min at 40C. Again all supernatant was removed by 
aspiration. Then the tube was kept in open condition until the ethanol has evaporated. Then 
the nuclic acid was dissolved in 50 µl of TE containing 20 µg/ml DNase free RNase A. Then 
plasmid was stored at -200C. (Fig: - 13) 
Clone Checking:- 
After the isolation of Plasmid clone checking was done with the help of 2% gel. Here 
the vector, Insert (DNMT 3A and DNMT 3B), and  isolated plasmid (DNMT 3A and DNMT 
3B) were loaded  in different lane of the gel(Fig-14). 
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6.Result 
36 
 
Quantification of RNA by Nanodrop:- 
• RNA was isolated from cancer tissue.  . 
• Quantification was carried out in Nano drop(Table-1). 
• The result show an average od value of ~1.6-1.7,conferming the purity of RNA sample. 
•  
Sample 260/280 Concentration 
Sample mix 1.278 116.2 µg/ml 
 
Table .1:-Quantification of RNA 
Primer Sequence:- 
DNMT 3A:-  
 
 
 
DNMT 3B:- 
 
 
 
 
 
 
 
 
Sense :- 5’CACACAGAAGCATATCCAGGAGTG 3’ 
Anti sense :- 5’AGTGGACTGGGAAACCAAATACCC 3’ 
 
 
Sence :- 5’AATGTGAATCCAGCCAGCCAGGAAAGGC 3’ 
Anti sense:- 5’ACTGGATTACACTCCAGGAACCGT3’ 
 
 PCR using β actin primer for the verification of cDNA
 
 
 
 
Primer Checking:-
                                        
DNMT 3A                                                      DNMT 3B
Fig :-7 cDNA checking with β-actin primer
 
Fig. 8  Primer Checking 
 
 
 
Marker β actin 
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:- 
 
 
 
 PCR amplification of target genes by desired primers:
When we amplified prepared
then the primer is amplified only that sequence of cDNA. After amplification we can check it 
by agarose gel electrophoresis in
documentation system. 
 
 
                                    
Gel elution of PCR amplified DNA product:
 
                                             
Before gel illutionAfter gel illution
DNMT 
3A 
 DNMT 
3B 
 cDNA with DNMT 3A and 3B gene specific primer 
 1% gel. After complete separation we
 
Fig:-9 PCR Amplification 
- 
         
                                           After gel illution
Fig:- 10 Gel elution 
1000bp
Marker 
DNMT 
3A 
DNMT 
3B 
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-       
 check it in gel 
    
 
DNMT 
3A 
DNMT 
3B 
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Cloning of PCR amplified DNMT 3A and DNMT 3B  gene:- 
 
 
Fig:- 11 pBlueScript SK- vector 
 
To calculate appropriate PCR product amount (insert) the equation is 
 
   ng of vector×kb size of insert   ×insert  : vector molar ratio  =3:1 
                     kilo base pair size of vector 
 
 
 
 
 
 
PROMEGA 
Multiple 
Cloning site 
(MCS) 
 Blue-white colony selection:
Transformation of competent ce
on LB/Amphicillin/IPTG/X-gal plates gives recombinant clones( white colonies) & control 
clones (Blue colonies) (fig:-7).
 
Fig.12
Plasmid Isolation:-
 
 
DNMT 3A
DNMT 3A 
- 
ll (DH5α) with the ligation mix followed by plating 
 
       
 
:- Blue-white colony selection 
 
                  
Fig.13:- Plasmid 
 DNMT 3B 
DNMT 3B
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Clone Checking :- 
 
    
                   
Fig:- 14 Clone checking 
 
 
 
 
 
 
 
DNMT 
3B 
DNMT 
3A 
DNMT 
3B 
 
1000bp
Marker 
DNMT 
3A 
Vector 
Insert Plasmid 
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7. Discussion 
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DNA (cytosine-5)-methyltransferase 3A is an enzyme that in humans is encoded by 
the DNMT3A gene  And DNA (cytosine-5-)-methyltransferase 3B, also known as DNMT3B, 
is code for DNMT3B. CpG methylation is an epigenetic modification that is important for 
embryonic development, genomic imprinting and X-chromosome inactivation. A threshold 
level of DNA methylation may be required for some essential developmental processes. This 
optimum methylation level is disrupted during tumorigenesis. Generally DNMT3A and 
DNMT3B overexpress and help in denovo methylation in cancer cell. In leukemia blood 
semple DNMT3A and DNMT3B overexpression is related to leukemia development and bad 
prognosis. DNMT3A and DNMT3B mediated methylation is related to cancer cell 
proliferation and tumor suppressor genes (TSGs) down regulation in leukemia.  
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8. Summary and Conclusion 
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DNMT 3A and DNMT 3B gene were cloned from human cancer tissue which is a 
highly preferred for their denovo methylation. The de novo activity of DNMT3 and its 
expression in early development indicate that it is the major enzyme responsible for re-
establishing methylation patterns. However, the DNMT3 enzymes are ineffective methylators 
of the DNA on their own. DNMT3A and DNMT3B cloning increase the chance of cancer 
research experiment and drug devlopment. Mechanism behind DNMT3A and DNMT3B 
involvement in cancer development will be clearer after developing DNMT3A and DNMT3B 
expressing cell. The cloning of the human DNMT3 genes will facilitate further biochemical 
and genetic studies of their functions in establishment of DNA methylation patterns, 
balancing of gene expression and tumorigenesis. 
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10. Appendix 
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1. DEPC treated water 
DEPC-Diethyl pyrocarbonate (C6H12O5). This water is used in laboratory to inactivate 
the RNase  enzyme from water and other lap utensils during RNA extraction which 
degrade the RNA.It inactivate the RNase by the covelent modification of histidine 
residue. 
                               For the preparation of DEPC treated water we add 100µl of fresh 
DEPC to 100 ml oh distil water to make final concentration of 0.5 %(V/V). Then 
incubated at 370C for at least 12hr and then autoclaved at 15lb pressure for 20 min to 
inactivate the remaining DEPC. 
2. Amphicilin stock solution 
 For the preparation of Amphicilin stock solution amphicilin 1gm was dissolved in 
10ml of deionised water and was sterilized by 0.2µm syringe filter. Aliquots were 
made by distributing 1ml of solution in 1.5 ml appendrof tubes and store at -200C. 
 For  LB agar plate concertration is 100µg. For each plate we use 200µl of amphicilin. 
3. IPTG stock solution 
IPTG-Isopropyl βD thayogalactosidi. IPTG is the inducer of β galactosidase. For the 
preparation of IPTG stock solution 0.24gm af IPTG was dissolved in 10ml of distilled 
water then filter sterilised it and stored at -200C. 
4. X-gal 
          X-gal:-5-Bromo,4-chloro,3-indolyl,β D galactopyranoside. It is a light 
sensitive compound. In gene cloning X-gal is used to indicate whether a cell express 
the β-galactoside enzyme which is encoded by Lac-Z gene in Blue-White screening. 
When X-gal and IPTG is present in a agar medium on a culture plate colonies which 
have a functional Lac-Z gene can be easily distinguished. Successful transformed 
bacteria has truncated β-galactosidase gene causing white colonies on the plate. But 
bacteri transformed by empty vector which don’t contain any insert in  
lac Z open reading frame are now able to produce the enzyme-galactosidase which 
can then cleave X-gal present in nutrient agar , resulting in blue colonies. 
                     For the preparation of  X-gal stock solution 100mg of    
X-gal was dissolved in 2 ml of N,N’,Dimethylformamide,mix well. Then aliquots 
were prepaired and stored at -200C for future use. 
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5. 75%  ethanol 
 
                Mix 75ml of absolute ethanol with 25ml of sterile water and not autoclaved, 
Then stored at-200C. 
 
6. TE buffer 
 
Component & final    Concentration Amount to added per 100ml 
 
10mM Tris 1ml (pH-7.8-8.0 at 250C) 
1mM EDTA 200µl of 0.5M(PH-8.0) 
H2O 98.8ml 
 
This standard buffer is used to resuspend and store DNA. 
 
7. 5X TBE buffer 
Component & Final concentration Amount to add per 1 lit 
445 mMtris base 54g 
245 mM borate 27.5 of boric acid 
10mM EDTA 20ml of 0.5 M(PH-8.0) 
H2O To make 100 lit 
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